Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018–January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32–43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34–38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
All Keywords
【저자키워드】 Europe, vaccination, Influenza, vaccine effectiveness, vaccines and immunisation, multicentre study, test-negative design,
【저자키워드】 Europe, vaccination, Influenza, vaccine effectiveness, vaccines and immunisation, multicentre study, test-negative design,